Join our Early Access Program to help improve our products and services
Applications for the Early Access Program are now open! Participants will have first access to our clinical hereditary cancer panel and enhanced reporting insights as we prepare for our broader market launch. Your feedback will help us fine-tune our analysis and reporting platforms so we can offer the best possible service to providers and patients across Canada.
Exclusive Benefits
Participants will have access to reduced-cost testing, enhanced reporting insights, dedicated support, report customization and more.
Help Us Better Serve You
We’re committed to setting a new standard in clinical genetic testing, and your feedback is critical to helping us get there!
Commitment to Collaboration
Trust and collaboration are our foundation. The Early Access Program is an important opportunity for us to work with the medical genetics community to help strengthen our national genomic infrastructure.
Program Overview
Enrolment in our Early Access Program is currently limited to qualified clinicians employed by an eligible medical genetics clinic or academic research institution within Canada. All requests will be reviewed by our program team, and those selected will contacted to review the terms of the Early Access Program and complete their enrolment. Clinicians can submit requests individually or on behalf of their organization. See our privacy policy for information on how applicant information is collected and used.
Step One: Apply Online
Follow the link below for complete program details, eligibility criteria and conditions. Spots are limited, and organization-wide participation is prioritized.
Step Two: Confirmation and Enrolment
Selected applicants will be contacted to confirm eligibility and complete program enrolment. Once enrolled, participants will be able to order our WGS-based Hereditary Cancer Complete testing and receive enhanced reporting insights.
Step Three: Feedback & Improvement
Participants will be asked to provide feedback related to TransCan Genomics products and services throughout the duration of the Early Access Program.